Role of Gastrointestinal Microbes on Digestion of Resistant Starch and Tryptophan Availability to Humans
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02974699|
Recruitment Status : Unknown
Verified May 2017 by Paul Burghardt, Wayne State University.
Recruitment status was: Recruiting
First Posted : November 28, 2016
Last Update Posted : May 4, 2017
|Condition or disease||Intervention/treatment||Phase|
|Type II Diabetes||Dietary Supplement: Potato Starch (Bob's Red Mill) Dietary Supplement: Pregelatinized Starch (Resource ThickenUp)||Early Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Basic Science|
|Study Start Date :||January 2017|
|Estimated Primary Completion Date :||December 2017|
Experimental: Potato Starch (Bob's Red Mill)
Daily dietary supplementation with Potato Starch (48g total/day) suspended in water. 24g will be consumed 2 times per day.
Dietary Supplement: Potato Starch (Bob's Red Mill)
Subjects will be assigned to Potato Starch (active) following assessment of their gut microbiome.
Placebo Comparator: Resource ThickenUp Pregelatinized Starch
Daily dietary supplementation with Pregelatinized Starch (48g total/day) suspended in water. 24g will be consumed 2 times per day.
Dietary Supplement: Pregelatinized Starch (Resource ThickenUp)
Subjects will be assigned to Pregelatinized Starch (placebo) following assessment of their gut microbiome.
- Plasma Amino Acid Levels [ Time Frame: Baseline ]
- Plasma Amino Acid Levels [ Time Frame: Following 4 weeks of supplementation ]
- Change in Plasma Amino Acid Levels [ Time Frame: Baseline vs. 4-weeks ]Difference in plasma amino acid levels between baseline and following 4-weeks of supplementation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02974699
|Contact: Paul R Burghardt, PhDemail@example.com|
|Contact: Katlin Chappelle, BSfirstname.lastname@example.org|
|United States, Michigan|
|Wayne State University||Recruiting|
|Detroit, Michigan, United States, 48202|
|Contact: Paul Burghardt 313-577-0107 email@example.com|